生物标志物 生物标志物
Anna Dewenter1, Benno Gesierich2, Anna Kopczak3
1Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Bavaria, Germany.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
一种新的扩散MRI标记物PSMD-2增强了检测小血管疾病 (SVD) 脑部变化的灵敏度. 这种改进的标记物减少了临床试验的样本大小要求,有助于监测SVD进展.
科学领域:
- 神经成像是一种神经成像.
- 扩散式核磁共振成像 (MRI)
- 脑血管疾病 脑血管疾病
背景情况:
- 小血管疾病 (SVD) 在老年人中很常见,与阿尔茨海默病有关.
- 传统的MRI标记器检测到晚期SVD阶段;扩散MRI指标识别早期变化.
- 骨化平均扩散率 (PSMD) 的峰值宽度是SVD的既定扩散MRI标志物.
研究的目的:
- 开发一种改进的扩散MRI标记物PSMD-2,用于对SVD进行纵向评估.
- 为了提高SVD临床试验的灵敏度和减少样本大小要求.
主要方法:
- PSMD-2是使用自由水校正的扩散图,主体内模板和常见骨开发的.
- 包括120名具有家族性SVD (CADASIL) 的受试者进行开发和89名受试者 (CADASIL,零星SVD) 进行验证.
- 通过估计假设临床试验的样本大小减少,将PSMD-2与PSMD进行比较.
主要成果:
- 在所有研究队列中,PSMD-2有效跟踪了疾病的进展.
- PSMD-2显示了所需样本大小的显著减少:24.3% (发展),31.0% (验证CADASIL) 和18.6% (验证零星SVD).
- 持续的验证包括脑粉样血管病变和可重复性/可重复性评估.
结论:
- 与PSMD相比,PSMD-2在检测与SVD相关的大脑变化方面具有更高的灵敏度.
- 该标记物显著减少了样本大小的需求,使其成为SVD临床试验的理想选择.
- PSMD-2对于监测SVD进展和阿尔茨海默病的并发性血管变化非常有价值.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511